Stueland Katherine sold WGS

September 9, 2025 · Form 4 insider transaction

Stueland Katherine sold 18 shares of GeneDx Holdings Corp. at $129.08 per share, a transaction worth $2.3K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Disposed (sell-side)
Shares
18
Price
$129.08
Total value
$2.3K
RoleOfficer, Director
SecurityClass A Common Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 9, 2025
Filing dateSeptember 11, 2025
Shares owned after6,329
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.; Following the reported sales, in addition to the 6,329 shares of Class A common stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned restricted stock units ("RSUs") representing contingent rights to receive up to an aggregate of 463,289 shares of Class A common stock and options to purchase up to an aggregate of 107,610 shares of Class A common stock, which RSUs and options vest according to their respective terms.

View the original Form 4 on SEC EDGAR